Market price volatility risk relating to investment securities
First written in FY2017. 7 of 19 entries say "Mitigated", first in FY2020-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2019: 54 of 136 companies on the "Worse" side.
- FY2026WorsenedAnnual report
「During the consolidated fiscal year, the company recognised impairment losses of ¥145 million on securities, consisting of shares classified as other securities.」
Impairment losses on investment securities increased from ¥106 million in the previous fiscal year to ¥145 million, and losses related to fluctuations in market prices and other factors continued to be recorded. - 2026-05-12MaterialisedEarnings
「Impairment loss on investment securities 106 145」
An impairment loss on investment securities of ¥145 million was recorded, up from ¥106 million in the previous fiscal year. - FY2025-H1MitigatedAnnual report
「Impairment losses on investment securities － 0」
Impairment losses on investment securities were ¥0 million for the interim consolidated accounting period, at the same level as the absence of such losses in the same period of the previous year. Following the recognition of ¥103 million in impairment losses in the previous fiscal year, virtually no new impairment losses were recorded in the interim period. - FY2024MaterialisedAnnual report
「During the consolidated fiscal year, the company recognised impairment losses of ¥103 million on securities, consisting of shares classified as other securities.」
Impairment losses on investment securities related to fluctuations in market prices and other factors increased from ¥15 million in the previous fiscal year to ¥103 million, resulting in the recording of risk-related losses. - FY2024-Q2MitigatedAnnual report
「Valuation loss on investment securities 0 —」
No impairment losses on investment securities were recorded during the cumulative second quarter, compared with ¥0 million in the same period of the previous year, resulting in “－”. - FY2023MaterialisedAnnual report
「There were impairment losses on investment securities of ¥15 million, among other extraordinary losses.」
The company recorded ¥15 million in impairment losses related to the risk of fluctuations in the market prices of investment securities during the fiscal year. - FY2023-Q3Decrease in investment securities balance, with virtually no impairment losses recordedAnnual report
「Investment securities 9,858 9,402」
The balance of investment securities decreased from ¥9,858 million at the end of the previous consolidated fiscal year to ¥9,402 million. Impairment losses on investment securities during the cumulative third quarter were ¥0 million. - FY2021MitigatedAnnual report
「Impairment losses on investment securities 258 9」
Impairment losses on investment securities decreased from ¥258 million in the previous fiscal year to ¥9 million. - FY2021-Q3MitigatedAnnual report
「Impairment losses on investment securities 1 －」
No impairment losses on investment securities were recorded in the cumulative third quarter, compared with ¥1 million in the same period of the previous year, resulting in “－”. No impairment losses related to the risk of fluctuations in market prices were recorded. - FY2021-Q1MitigatedAnnual report
「Impairment losses on investment securities 1 －」
No impairment losses on investment securities were recorded in the cumulative first quarter, compared with ¥1 million in the same period of the previous year, resulting in “－”. Impairment losses related to the risk of fluctuations in market prices have decreased further. - FY2020-Q3MitigatedAnnual report
「Impairment losses on investment securities 468 1」
Impairment losses on investment securities amounted to ¥1 million in the cumulative third quarter, down significantly from ¥468 million in the same period of the previous year. Losses related to the risk of fluctuations in market prices have decreased. - FY2020-Q1MitigatedAnnual report
「Impairment losses on investment securities 395 1」
Impairment losses on investment securities amounted to ¥1 million in the cumulative first quarter, down significantly from ¥395 million in the same period of the previous year. Losses related to the risk of fluctuations in market prices have decreased. - FY2019-Q3Increase in impairment losses on investment securities in the cumulative third quarterAnnual report
「Impairment losses on investment securities 339 468」
Impairment losses on investment securities amounted to ¥468 million in the cumulative third quarter, up from ¥339 million in the same period of the previous year. Losses related to the risk of fluctuations in market prices continued to be recorded. - FY2019-Q2Impairment loss on investment securities increasedAnnual report
「Impairment losses on investment securities 395 407」
Impairment losses on investment securities amounted to ¥407 million in the cumulative second quarter, up from ¥395 million in the same period of the previous year. - FY2019-Q1Impairment losses on investment securities also recorded in the first quarterAnnual report
「Impairment losses on investment securities 367 395」
The company recorded ¥395 million in impairment losses on investment securities during the cumulative first quarter, up from ¥367 million in the same period of the previous year. - FY2018-Q3Impairment losses on investment securities recorded in the cumulative third quarterAnnual report
「Impairment losses on investment securities － 339」
The company recorded ¥339 million in impairment losses on investment securities during the cumulative third quarter. Losses related to the risk of fluctuations in the market prices of investment securities continued to be recorded, although the filing does not specifically explain the cause of the impairment losses. - FY2018-Q2Increase in Valuation Losses on Investment SecuritiesAnnual report
「Impairment losses on investment securities － 395」
Impairment losses on investment securities amounted to ¥395 million in the cumulative second quarter, compared with no impairment losses recorded in the same period of the previous year. Specific losses related to fluctuations in the market prices of investment securities continued to be recorded. - FY2018-Q1MaterialisedAnnual report
「Impairment losses on investment securities 59 367」
The company recorded impairment losses on investment securities of ¥367 million in the first quarter, up from ¥59 million in the same period of the previous year. The filing does not specifically explain whether the impairment losses were caused by fluctuations in market prices. - FY2017First statedAnnual report
「Marketable securities and investment securities consist mainly of bonds held to maturity and shares related to business or capital alliances with business partners, and are exposed to the risk of fluctuations in market prices.」
Investment securities recorded on the consolidated balance sheet amounted to ¥8,644 million. The disclosure addresses the risk of fluctuations in market prices, quarterly monitoring of issuers' financial condition and reviews of holdings.